Jennifer Postelnek

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Daigen Xu, Yong Kim, Jennifer Postelnek et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 140 citations

Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation

Tai-An Lin, Kim W. McIntyre, Jagabandhu Das et al. · Biochemistry · 2004 · 111 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, T-regulatory Cell +21

Suppression of Glomerulonephritis in Lupus‐Prone NZB × NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase

Paola Mina‐Osorio, Jacob LaStant, Natalie Keirstead et al. · Arthritis & Rheumatism · 2013 · 82 citations

Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors

Lillian L. Siu, Howard A. Burris, Dung T. Le et al. · Cancer Research · 2018 · 63 citations

Preliminary Phase 1, Immunology, Immunoediting +21

Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis

Connie Kliwinski, Daniel Kukral, Jennifer Postelnek et al. · Journal of Autoimmunity · 2005 · 42 citations

Inflammation, Rheumatology, Rheumatoid Disorder +11